Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adhera Therapeutics
Adhera Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Prestalia
Perindopril arginine
,
Amlodipine besylate
2015-01-21
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Benzocaine
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
autistic disorder
,
choroidal neovascularization
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
macular edema
,
macular degeneration
,
edema
,
lupus nephritis
,
nephritis
,
retinal vein occlusion
,
wet macular degeneration
,
diabetic nephropathies
,
renal cell carcinoma
,
bcr-abl positive chronic myelogenous leukemia
,
melanoma
,
myasthenia gravis
,
retinal neovascularization
,
anemia
,
chronic renal insufficiency
,
kidney diseases
,
kidney transplantation
,
chronic kidney failure
Aglatimagene besadenovec
leiomyoma
,
myofibroma
,
head and neck neoplasms
,
esophageal neoplasms
,
disease progression
,
neuroendocrine carcinoma
,
disease
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
,
large b-cell lymphoma diffuse
,
carcinoma
,
urogenital neoplasms
,
male genital neoplasms
,
lymphoma
,
small cell lung carcinoma
,
renal cell carcinoma
,
male genital diseases
,
prostatic diseases
,
abdominal neoplasms
,
genital diseases
,
leukemia
,
myelomonocytic leukemia chronic
,
systemic mastocytosis
,
myelomonocytic leukemia juvenile
,
hypereosinophilic syndrome
,
mastocytosis
,
dermatofibrosarcoma
,
hematologic neoplasms
,
sarcoma
,
b-cell lymphoma
,
neuroendocrine tumors
,
renal insufficiency
,
urologic neoplasms
,
kidney neoplasms
,
endometrial neoplasms
,
t-cell lymphoma
,
malignant mesothelioma
,
clear cell adenocarcinoma
,
mesothelioma
,
adenomyoepithelioma
,
anemia
,
thrombocytopenia
,
pancytopenia
,
cytopenia
,
x-linked bulbo-spinal atrophy
,
neoplasms
,
osteoporosis
,
lung neoplasms
,
pain
,
recurrence
,
bone resorption
,
hypercalcemia
,
prostatic neoplasms
,
neoplasm metastasis
,
breast neoplasms
,
bone neoplasms
,
bone marrow diseases
,
multiple myeloma
,
second primary neoplasms
,
plasma cell neoplasms
,
hypersensitivity
,
plasmacytoma
,
osteonecrosis
Intermedine
prostatic neoplasms
,
breast neoplasms
,
neoplasms
Isoxaflutole
healthy volunteers/patients
,
cardiovascular diseases
,
asthma
,
alzheimer disease
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
,
pain
,
rheumatoid arthritis
,
arthritis
,
neoplasms
,
neoplasm metastasis
,
triple negative breast neoplasms
,
parkinson disease
,
psychotic disorders
,
mental disorders
,
heart failure
,
breast neoplasms
,
non-small-cell lung carcinoma
,
prostatic neoplasms
,
pancreatic neoplasms
,
sarcoma
,
ovarian neoplasms
,
endometrioid carcinoma
,
mucinous cystadenocarcinoma
,
fallopian tube neoplasms
,
acinar cell carcinoma
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use